By Adria Calatayud

GlaxoSmithKline PLC (GSK.LN) said Wednesday that Jonathan Symonds, currently deputy chairman of HSBC Holdings PLC (HSBA.LN), will succeed Philip Hampton as nonexecutive chairman with effect from Sept. 1.

Mr. Symonds is a former chief financial officer of Novartis AG (NOVN.EB) and AstraZeneca PLC (AZN.LN), the FTSE 100-listed pharmaceutical company said. He is currently nonexecutive chairman of Proteus Digital Health Inc., a nonexecutive director of Rubius Therapeutics Inc. (RUBY) and chairman of Genomics England Ltd., the company said.

GlaxoSmithKline is due to report second-quarter earnings later on Wednesday.

Write to Adria Calatayud at adria.calatayudvaello@dowjones.com

(END) Dow Jones Newswires

July 24, 2019 05:25 ET (09:25 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
HSBC (NYSE:HSBC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more HSBC Charts.
HSBC (NYSE:HSBC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more HSBC Charts.